Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Humana (HUM) Partners With MDLIVE, Improves MA Plans

Published 11/07/2016, 08:08 PM
Updated 07/09/2023, 06:31 AM
HUM
-
UNH
-
INFIQ
-
WCG
-

Humana Inc. (NYSE:HUM) recently joined forces with MDLIVE, a renowned telemedicine services and software provider, to improve its Medicare Advantage (MA) plans in Georgia. The alliance mainly aims to provide virtual access to doctors in selected counties across Georgia and South Carolina to the Medicare beneficiaries of Humana. MDLIVE’s board-certified doctors are already known for catering to patients’ needs and hence, the alliance will benefit Humana’s MA members. This is the first year of telemedicine benefit offered on Humana’s Regional Medicare Advantage PPO plans in the concerned counties.

This telemedicine benefit will be added to certain MA plans of Humana that are to be offered in 2017. Notably, Humana offered this benefit on a few plans in 2016 as well and received immense appreciation from its members. Members opting for these special plans will gain access to doctors through computers, telephones or mobile devices. The doctors can be contacted for numerous non-emergency conditions as well with the appropriate co-pay for each visit.

With this telemedicine benefit, doctors can now be easily reached even beyond their scheduled working hours. People who have difficulties in travelling due to illness can also gain access to doctors by enrolling into these special MA plans.

However, the telemedicine benefit will not be applicable for emergency situations or chronic conditions like heart disease or diabetes. The telemedicine benefit also does not substitute an in-person visit with a primary care physician or other provider. Nonetheless, the restrictions on healthcare and prescription services offered by the telemedicine benefit differ according to the concerned state.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Humana’s clinical data technology ensures that individual health records remain available to the MDLIVE physicians’ network. The MDLIVE clinicians’ prescribed treatment will also be shared with the members’ primary care physicians to maintain transparency at both ends. Existing Medicare members may choose the plans between Oct 15 and Dec 7, 2016 –the annual Medicare Advantage and Prescription Drug Plan enrollment period. Those that opt for the plan with telemedicine benefit will be eligible to start using the service from Jan 1, 2017.

Humana remains committed to helping its members achieve optimal health by providing innovative and value-added solutions that cater to customers’ changing healthcare needs. We note that growing enrollment drove the company’s solid results in third-quarter 2016. Humana presently carries Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

HUMANA INC NEW Price

Other Stocks to Consider

Investors can also look at other well-ranked medical sector stocks like WellCare Health Plans Inc. (NYSE:WCG) , UnitedHealth Group Inc. (NYSE:UNH) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI) .

WellCare sports a Zacks Rank #1. The company delivered positive surprise in the last four quarters with an average beat of 40.01%

Another Zacks Rank #1 medical sector stock is Infinity Pharma. The company delivered positive surprises in each of the last four straight quarters with an average beat of 67.62%.

UnitedHealth carries a Zacks Rank #2. The company delivered positive surprises in all the last four quarters with a average beat of 3.86%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand.Click to see them now>>



INFINITY PHARMA (INFI): Free Stock Analysis Report

HUMANA INC NEW (HUM): Free Stock Analysis Report

UNITEDHEALTH GP (UNH): Free Stock Analysis Report

WELLCARE HEALTH (WCG): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.